Insomnia News and Research

Latest Insomnia News and Research

Tai Chi, better sleep quality reduce inflammation, depression and age-related morbidities

Inflammatory processes occur throughout the body, with a primary function of promoting healing after injury. However, when too active, these inflammatory processes can also damage the body in many ways, and may contribute to heart disease, stroke, certain cancers, and other significant medical problems.

6 Nov 2015

Sleepwalkers don't feel pain while suffering injuries

A new study of sleepwalkers found an intriguing paradox: Although sleepwalkers have an increased risk for headaches and migraines while awake, during sleepwalking episodes they are unlikely to feel pain even while suffering an injury.

4 Nov 2015

United Cannabis files utility and PCT patent applications related to unique specifications of cannabinoids

United Cannabis Corporation today announced that it moved its provisional patent application to the next phase by filing a utility patent application related to the unique combinations of pharmaceutically active cannabinoids used to treat disorders of the nervous system, immune system and cancer with the U.S. Patent and Trademark Office.

3 Nov 2015

Chronic pain sufferers may benefit from therapy to help them sleep better, study finds

Research conducted at the University of Warwick indicates that chronic pain sufferers could benefit from therapy to help them sleep better.

31 Oct 2015

Interrupted sleep affects people's positive moods

A study led by Johns Hopkins Medicine researchers suggests that awakening several times throughout the night is more detrimental to people's positive moods than getting the same shortened amount of sleep without interruption.

31 Oct 2015

Alexza plans to reacquire U.S. rights for ADASUVE (loxapine) inhalation powder from Teva

Alexza Pharmaceuticals, Inc. announced today that it plans to reacquire the U.S. rights for ADASUVE (loxapine) inhalation powder from Teva Pharmaceuticals USA, Inc., a subsidiary of Teva Pharmaceutical Industries Ltd., with an estimated target completion date of January 1, 2016.

31 Oct 2015

Reducing depression to a checklist of symptoms may not be useful, new research reveals

How can you tell if someone is depressed? The Diagnostic and Statistical Manual of Mental Disorders (DSM) - the 'bible' of psychiatry - diagnoses depression when patients tick off a certain number of symptoms on the DSM checklist. A large-scale quantitative study coordinated at KU Leuven, Belgium, now shows that some symptoms play a much bigger role than others in driving depression, and that the symptoms listed in DSM may not be the most useful ones.

26 Oct 2015

Melatonin and the circadian rhythm: an interview with Professor Kennaway, University of Adelaide

The production of melatonin is controlled by a part of the brain called the suprachiasmatic nucleus (SCN) and its timing fine-tuned by our exposure to light during the morning.

20 Oct 2015

Sprout announces U.S. availability of Addyi for HSDD treatment in premenopausal women

Sprout Pharmaceuticals, Inc., a division of Valeant Pharmaceuticals North America LLC, announced today that Addyi, a once-daily, non-hormonal pill for the treatment of acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women, is now available in the United States through certified physicians and pharmacies.

19 Oct 2015

BDSI announces FDA approval of BUNAVAIL sNDA for manufacturing specification change

BioDelivery Sciences International, Inc. announced that the U.S. Food and Drug Administration has approved the company's Supplemental New Drug Application (sNDA) for a manufacturing specification change for BUNAVAIL (buprenorphine and naloxone) buccal film (CIII).

15 Oct 2015

Perimenopausal women at greater risk for developing insomnia

Millions of women may likely be sleep-deprived. It's already a known fact that women are more predisposed to insomnia. Now a new study presented at the 2015 Annual Meeting of The North American Menopause Society earlier this month suggests that perimenopausal women have an even greater risk for developing insomnia. Considering that perimenopause will affect roughly 500 million women within the next decade, that's a lot of tired women.

15 Oct 2015

Benzodiazepines heighten risks for dementia and death

Patients taking benzodiazepines to treat psychiatric conditions should consider transitioning to other therapies because of heightened risks for dementia and death, according to clinicians from the American College of Osteopathic Neurologists and Psychiatrists.

6 Oct 2015

Osteopathic physicians, researchers to present clinical and research updates at OMED 15

Osteopathic physicians, researchers and aligned medical professionals will present clinical and research updates in 15 specialties at OMED 15 in Orlando October 17-21.

6 Oct 2015

Study: Bright light therapy reduces depression and agitation in dementia sufferers

Dementia is most often associated with memory loss, but seniors who suffer from the condition also experience depression and agitation. These symptoms are often treated with medication.

29 Sep 2015

Combination of two targeted therapies increases survival in advanced melanoma

Latest results from a trial of a combination of two targeted therapies (dabrafenib and trametinib) to treat advanced melanoma have shown that patients are living significantly longer on the combined therapy than patients treated with another drug, vemurafenib, when used alone.

28 Sep 2015

Brain health: how can you reduce cognitive decline? An interview with Heather Snyder, Ph.D.

Reader’s Digest and the Alzheimer’s Association partnered to survey approximately 1,600 people in May 2015 about their brain health and their knowledge of how lifestyle habits affect cognitive decline and dementia.

22 Sep 2015

Study shows reduced heart rate variability may be contributing risk factor for PTSD

A prospective longitudinal study of U.S. Marines suggests that reduced heart rate variability - the changing time interval between heartbeats - may be a contributing risk factor for post-traumatic stress disorder (PTSD).

11 Sep 2015

Egalet announces launch of OXAYDO (oxycodone HCI, USP) Tablets and IMPACT-Rx initiative

Egalet Corporation, a fully integrated specialty pharmaceutical company focused on discovering, developing and commercializing innovative pain treatments, today announced the launch of OXAYDO (oxycodone HCI, USP) tablets -CII in the United States.

9 Sep 2015

Vernalis Therapeutics announces availability of codeine-based cough and cold syrup in the U.S.

Vernalis Therapeutics Inc., a subsidiary of Vernalis plc, today announced that Tuzistra XR (codeine polistirex and chlorpheniramine polistirex), extended-release oral suspension, CIII (DEA Schedule III) is now available to adult patients and physicians in the United States.

8 Sep 2015

Bedwetting symptom may help identify OSA in post-menopausal women

The results of a new study suggest that nocturnal enuresis, or bedwetting, may be an additional symptom that doctors can look for when assessing post-menopausal women for obstructive sleep apnea. That condition left untreated can lead to serious medical problems, such as cardiovascular disease, as organs are undersupplied with oxygen.

3 Sep 2015

Insomnia News and Research

Latest Insomnia News and Research

Tai Chi, better sleep quality reduce inflammation, depression and age-related morbidities

Sleepwalkers don't feel pain while suffering injuries

United Cannabis files utility and PCT patent applications related to unique specifications of cannabinoids

Chronic pain sufferers may benefit from therapy to help them sleep better, study finds

Interrupted sleep affects people's positive moods

Alexza plans to reacquire U.S. rights for ADASUVE (loxapine) inhalation powder from Teva

Reducing depression to a checklist of symptoms may not be useful, new research reveals

Melatonin and the circadian rhythm: an interview with Professor Kennaway, University of Adelaide

Sprout announces U.S. availability of Addyi for HSDD treatment in premenopausal women

BDSI announces FDA approval of BUNAVAIL sNDA for manufacturing specification change

Perimenopausal women at greater risk for developing insomnia

Benzodiazepines heighten risks for dementia and death

Osteopathic physicians, researchers to present clinical and research updates at OMED 15

Study: Bright light therapy reduces depression and agitation in dementia sufferers

Combination of two targeted therapies increases survival in advanced melanoma

Brain health: how can you reduce cognitive decline? An interview with Heather Snyder, Ph.D.

Study shows reduced heart rate variability may be contributing risk factor for PTSD

Egalet announces launch of OXAYDO (oxycodone HCI, USP) Tablets and IMPACT-Rx initiative

Vernalis Therapeutics announces availability of codeine-based cough and cold syrup in the U.S.

Bedwetting symptom may help identify OSA in post-menopausal women

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Shaping the future of lab automation through AI and robotics

Insomnia News and Research

Latest Insomnia News and Research

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Shaping the future of lab automation through AI and robotics

Newsletters you may be interested in